References
- Nelson SM, Ferguson LR, Denny WA. Non-covalent ligand/DNA interactions: minor groove binding agents. Mutat Res 2007;623:24–40.
- Neidle S. DNA minor-groove recognition by small molecules. Nat Prod Rep 2001;18:291–309.
- Baraldi PG, Bovero A, Fruttarolo F, Preti D, Tabrizi MA, Pavani MG, et al. DNA minor groove binders as potential antitumor and antimicrobial agents. Med Res Rev 2004;24:475–528.
- Bailly C. Sequence-specific recognition and modification of double-helical DNA by minor-groove binding conjugates structurally related to netropsin and distamycin. In: Palumbo M, ed. Advances in DNA Sequence-Specific Agents. London: JAI Press, 1998;3:97-156.
- Kopka ML, Yoon C, Goodsell D, Pjura P, Dickerson RE. The molecular origin of DNA-drug specificity of netropsin and distamycin. Proc Natl Acad Sci USA 1985;82:1376–80.
- Pindur U, Jansen M, Lemster T. Advances in DNA-ligands with groove binding, intercalating and/or alkylating activity: chemistry, DNA-binding and biology. Curr Med Chem 2005;12:2805–47.
- Bartulewicz D, Markowska A, Wołczyński S, Dąbrowska M, Różański A. Molecular modelling, synthesis and antitumour activity of carbocyclic analogues of netropsin and distamycin – new carriers of alkylating elements. Acta Biochim Polon 2000;47:23–35.
- Bartulewicz D, Bielawski K, Bielawska A, Różański A. Synthesis, molecular modelling, and antiproliferative and cytotoxic effects of carbocyclic derivatives of distamycin with chlorambucil moiety. Eur J Med Chem 2001;36:461–7.
- Bielawski K, Bielawska A, Bartulewicz D, Różański A. Molecular modelling of the interaction of carbocyclic analogues of netropsin and distamycin with d(CGCGAATTCGCG)2. Acta Biochim Polon 2000;47:855–66.
- Drozdowska D, Rusak M, Miltyk W, Midura-Nowaczek K. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents. Arch Pharm Chem Life Sci 2009;342:87-93.
- Bartulewicz D, Anchim T, Midura-Nowaczek K. Synthesis and cytotoxic effect of carbocyclic potential minor groove binders. Farmaco 2004;59:211–14.
- Morgan AR, Lee JS, Pulleyblank DE, Murray NL, Evans DH. Ethidium fluorescence assays 1. Physiochemical studies. Nucleic Acids Res 1979;7:547–69.
- Debart F, Periguad C, Gosselin D, Mrani D, Rayner B, Le Ber P, et al. Synthesis, DNA binding, and biological evaluation of synthetic precursors and novel analogues of netropsin. J Med Chem 1989;32:1074–83.
- Schmitt M, Wilhelm OG, Reuning U, Krüger A, Harbeck N, Lengyel E, et al. The urokinase plasminogen activator system as a novel target for tumour therapy. Fibrinolysis Proteolysis 2000;14:114–32.
- Andreasen PA, Kjoller L, Christensen J, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997;72:1–22.
- Pućkowska A, Midura-Nowaczek K, Bruzgo I. Effects of netropsin and pentamidine amino analogues on the amidolytic activity of plasmin, trypsin and urokinase. Acta Polon Pharm 2008;65:213-215.
- Okada Y, Tsuda Y, Teno N, Wanaka K, Bohgaki M, Hijikata-Okunomiya A, et al. Synthesis of active center-directed peptide inhibitors of plasmin. Chem Pharm Bull 1988;36:1289–97.
- Tamura S, Weinhouse MI, Roberts CA, Goldman EA, Masukawa K, Anderson SM, et al. Synthesis and biological activity of peptidyl aldehyde urokinase inhibitors. Biorg Med Chem Lett 2000;10:983–7.
- Lown JW. Newer approaches to the study of the mechanisms of action of antitumor antibiotics. Acc Chem Res 1982;15:381–7.
- Bartulewicz D, Bielawski K, Bielawska A. Carbocyclic analogues of netropsin and distamycin: DNA-binding properties and inhibition of DNA topoisomerases. Arch Pharm Pharm Med Chem 2002;9:422–6.
- Capranico G, Borginetto ME, Cornarotti M, Zagni E, Palumbo M, Zunino F Sequence-specific poisons of type II DNA topoisomerases. In: Palumbo M, ed. Advances in DNA Sequence-Specific Agents. London: JAI Press, 1998;3:7–38.
- Gatto B, Fong Liu L. Topoisomerase I-targeting drugs: new developments in cancer pharmacology. In: Palumbo M, ed. Advances in DNA Sequence-Specific Agents. London: JAI Press, 1998;3:39–66.
- Champoux JJ. DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem 2001;70:369–413.
- Dass K, Ahmad A, Azmi AS, Sarkar SH, Sarkar FH. Evolving role of uPA/uPAR system in human cancers. Cancer Treat Rev 2008;34:122–36.